• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于外周血淋巴细胞模式无创性方法预测非酒精性脂肪性肝炎重叠自身免疫性肝炎的危险因素。

Noninvasive approach to indicate risk factors of nonalcoholic steatohepatitis overlapping autoimmune hepatitis based on peripheral lymphocyte pattern.

机构信息

Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.

Division for Health Service Promotion, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.

出版信息

J Gastroenterol. 2023 Dec;58(12):1237-1251. doi: 10.1007/s00535-023-02038-y. Epub 2023 Sep 14.

DOI:10.1007/s00535-023-02038-y
PMID:37707595
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10657798/
Abstract

BACKGROUND

Nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) clinically includes autoimmunity as indicated by antinuclear antibody (ANA) positivity and overlap of autoimmune hepatitis (AIH). Discriminating AIH-overlap NASH from NAFLD/NASH is required for proper treatment, and typically involves pathological diagnosis by invasive liver biopsy. Differential patterns of peripheral lymphocytes in NAFLD and AIH were assessed to noninvasively indicate risk factors of AIH-overlap NASH by flow cytometry (FCM).

METHODS

We assessed the differential frequencies of peripheral lymphocytes in 115 patients: 70 NASH (ANA negative:positive:AIH-overlap = 36:20:14), 18 NAFL, and 27 AIH (acute:chronic = 12:15) patients diagnosed by FCM. We focused on the following populations of lymphocytes: T cells, B cells, natural killer (NK) cells, NKT cells, helper T cell (Th) subsets (Th1, Th2, and Th17), and regulatory T cells; we also examined programmed cell death (PD) 1 and cytotoxic T-lymphocyte antigen levels.

RESULTS

Several significant differences in laboratory parameters and peripheral lymphocyte frequencies were found among the NAFLD and AIH subgroups. In univariate and multivariate analyses, hyaluronic acid level, liver stiffness, and the frequencies of Th17 and CD8 PD1 T cells were independent risk factors of NASH in NAFLD. Regarding overlap of AIH, only the frequency of CD8 PD1 T cells (odds ratio, 0.01; 95% CI 0.00-38.9, p = 0.004) was an independent risk factor in NASH and significantly decreased in AIH.

CONCLUSIONS

The decreased frequency of peripheral CD8 PD1 T cells is an independent risk factor of NASH overlapping with AIH in the present cohort. Our findings will facilitate development of a new noninvasive FCM method for indicating risk factors of NASH, including autoimmunity.

摘要

背景

非酒精性脂肪性肝病(NAFLD)/非酒精性脂肪性肝炎(NASH)临床上包括自身免疫,表现为抗核抗体(ANA)阳性和自身免疫性肝炎(AIH)重叠。区分 AIH 重叠性 NASH 与 NAFLD/NASH 对于正确治疗是必需的,通常涉及通过侵入性肝活检进行病理诊断。通过流式细胞术(FCM)评估 NAFLD 和 AIH 中外周淋巴细胞的差异模式,以无创方式指示 AIH 重叠性 NASH 的危险因素。

方法

我们评估了 115 例患者的外周淋巴细胞差异频率:70 例 NASH(ANA 阴性:阳性:AIH 重叠=36:20:14),18 例 NAFL 和 27 例 AIH(急性:慢性=12:15)患者由 FCM 诊断。我们重点关注以下淋巴细胞群体:T 细胞、B 细胞、自然杀伤(NK)细胞、NKT 细胞、辅助 T 细胞(Th)亚群(Th1、Th2 和 Th17)和调节性 T 细胞;我们还检查了程序性细胞死亡(PD)1 和细胞毒性 T 淋巴细胞抗原水平。

结果

在 NAFLD 和 AIH 亚组中,实验室参数和外周淋巴细胞频率存在几个显著差异。在单变量和多变量分析中,透明质酸水平、肝硬度以及 Th17 和 CD8 PD1 T 细胞的频率是 NAFLD 中 NASH 的独立危险因素。关于 AIH 的重叠,只有 CD8 PD1 T 细胞的频率(比值比,0.01;95%置信区间 0.00-38.9,p=0.004)是 NASH 的独立危险因素,在 AIH 中显著降低。

结论

本研究队列中,外周 CD8 PD1 T 细胞频率降低是 AIH 重叠性 NASH 的独立危险因素。我们的发现将促进开发一种新的非侵入性 FCM 方法,用于指示包括自身免疫在内的 NASH 的危险因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5887/10657798/044986f7a71e/535_2023_2038_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5887/10657798/3ebae7e76ab0/535_2023_2038_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5887/10657798/5bcfb212f858/535_2023_2038_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5887/10657798/044986f7a71e/535_2023_2038_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5887/10657798/3ebae7e76ab0/535_2023_2038_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5887/10657798/5bcfb212f858/535_2023_2038_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5887/10657798/044986f7a71e/535_2023_2038_Fig3_HTML.jpg

相似文献

1
Noninvasive approach to indicate risk factors of nonalcoholic steatohepatitis overlapping autoimmune hepatitis based on peripheral lymphocyte pattern.基于外周血淋巴细胞模式无创性方法预测非酒精性脂肪性肝炎重叠自身免疫性肝炎的危险因素。
J Gastroenterol. 2023 Dec;58(12):1237-1251. doi: 10.1007/s00535-023-02038-y. Epub 2023 Sep 14.
2
Treatment responses and outcomes in patients with autoimmune hepatitis and concomitant features of non-alcoholic fatty liver disease.自身免疫性肝炎合并非酒精性脂肪性肝病患者的治疗反应及结局
JHEP Rep. 2023 Apr 22;5(8):100778. doi: 10.1016/j.jhepr.2023.100778. eCollection 2023 Aug.
3
Prevalence and Clinical Significance of Autoantibodies in Children with Overweight and Obesity with Nonalcoholic Fatty Liver Disease.超重和肥胖伴非酒精性脂肪性肝病儿童自身抗体的流行率及临床意义。
J Pediatr. 2021 Dec;239:155-160. doi: 10.1016/j.jpeds.2021.08.041. Epub 2021 Aug 27.
4
Natural History of Patients Presenting with Autoimmune Hepatitis and Coincident Nonalcoholic Fatty Liver Disease.自身免疫性肝炎合并非酒精性脂肪性肝病患者的自然病史。
Dig Dis Sci. 2016 Sep;61(9):2710-20. doi: 10.1007/s10620-016-4213-3. Epub 2016 Jun 4.
5
Diagnosing autoimmune hepatitis in nonalcoholic fatty liver disease: is the International Autoimmune Hepatitis Group scoring system useful?在非酒精性脂肪性肝病中诊断自身免疫性肝炎:国际自身免疫性肝炎小组评分系统有用吗?
J Gastroenterol. 2005 Dec;40(12):1130-8. doi: 10.1007/s00535-005-1711-z.
6
Progression from Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis Is Marked by a Higher Frequency of Th17 Cells in the Liver and an Increased Th17/Resting Regulatory T Cell Ratio in Peripheral Blood and in the Liver.从非酒精性脂肪肝进展为非酒精性脂肪性肝炎的特征是肝脏中Th17细胞频率更高,以及外周血和肝脏中Th17/静息调节性T细胞比例增加。
J Immunol. 2016 Jan 1;196(1):97-105. doi: 10.4049/jimmunol.1501175. Epub 2015 Nov 30.
7
Noninvasive diagnostic criteria for nonalcoholic steatohepatitis based on gene expression levels in peripheral blood mononuclear cells.基于外周血单个核细胞基因表达水平的非酒精性脂肪性肝炎无创性诊断标准。
J Gastroenterol. 2019 Aug;54(8):730-741. doi: 10.1007/s00535-019-01565-x. Epub 2019 Mar 4.
8
Differential peripheral memory T cell subsets sensitively indicate the severity of nonalcoholic fatty liver disease.外周记忆性T细胞亚群差异可灵敏指示非酒精性脂肪性肝病的严重程度。
Hepatol Res. 2024 Jun;54(6):525-539. doi: 10.1111/hepr.14009. Epub 2024 Jan 16.
9
Autoimmune Antibodies in Children and Adolescents With Nonalcoholic Fatty Liver Disease.自身免疫抗体在非酒精性脂肪性肝病儿童和青少年中的研究
J Pediatr Gastroenterol Nutr. 2022 Sep 1;75(3):264-268. doi: 10.1097/MPG.0000000000003534. Epub 2022 Jun 27.
10
The Efficacy of Corticosteroid Therapy in a Patient with Non-alcoholic Steatohepatitis Overlapping Autoimmune Hepatitis.皮质类固醇疗法对一名非酒精性脂肪性肝炎合并自身免疫性肝炎患者的疗效
Intern Med. 2018 Mar 15;57(6):807-812. doi: 10.2169/internalmedicine.8887-17. Epub 2017 Nov 20.

引用本文的文献

1
Decreased antioxidant-related superoxide dismutase 1 expression in peripheral immune cells indicates early ethanol exposure.外周免疫细胞中抗氧化相关超氧化物歧化酶 1 表达降低表明早期乙醇暴露。
Sci Rep. 2024 Oct 23;14(1):25091. doi: 10.1038/s41598-024-76084-8.

本文引用的文献

1
SWOT analysis of noninvasive tests for diagnosing NAFLD with severe fibrosis: an expert review by the JANIT Forum.非侵入性检测诊断严重纤维化非酒精性脂肪性肝病的 SWOT 分析:JANIT 论坛专家评论。
J Gastroenterol. 2023 Feb;58(2):79-97. doi: 10.1007/s00535-022-01932-1. Epub 2022 Dec 5.
2
Noninvasive assessment of liver fibrosis and its clinical significance in nonalcoholic fatty liver disease.非酒精性脂肪性肝病中肝纤维化的无创评估及其临床意义
Hepatol Res. 2022 Jun;52(6):497-507. doi: 10.1111/hepr.13764. Epub 2022 Apr 12.
3
Peripheral immune cells in NAFLD patients: A spyhole to disease progression.
非酒精性脂肪性肝病患者的外周免疫细胞:疾病进展的窥探孔。
EBioMedicine. 2022 Jan;75:103768. doi: 10.1016/j.ebiom.2021.103768. Epub 2021 Dec 17.
4
Immune cell-mediated features of non-alcoholic steatohepatitis.免疫细胞介导的非酒精性脂肪性肝炎特征。
Nat Rev Immunol. 2022 Jul;22(7):429-443. doi: 10.1038/s41577-021-00639-3. Epub 2021 Nov 5.
5
Lymphocyte Profile and Immune Checkpoint Expression in Drug-Induced Liver Injury: An Immunophenotyping Study.药物性肝损伤的淋巴细胞谱和免疫检查点表达:免疫表型研究。
Clin Pharmacol Ther. 2021 Dec;110(6):1604-1612. doi: 10.1002/cpt.2423. Epub 2021 Oct 3.
6
Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020.2020 年非酒精性脂肪性肝病/非酒精性脂肪性肝炎临床实践循证指南。
J Gastroenterol. 2021 Nov;56(11):951-963. doi: 10.1007/s00535-021-01796-x. Epub 2021 Sep 17.
7
CD8 tissue-resident memory T cells promote liver fibrosis resolution by inducing apoptosis of hepatic stellate cells.CD8 组织驻留记忆 T 细胞通过诱导肝星状细胞凋亡促进肝纤维化消退。
Nat Commun. 2021 Jul 22;12(1):4474. doi: 10.1038/s41467-021-24734-0.
8
Immunoglobulin G4 (IgG4)-related autoimmune hepatitis and IgG4-hepatopathy: A histopathological and clinical perspective.免疫球蛋白G4(IgG4)相关自身免疫性肝炎和IgG4肝病:组织病理学和临床视角
Hepatol Res. 2021 Aug;51(8):850-859. doi: 10.1111/hepr.13683. Epub 2021 Jun 24.
9
OMIP 071: A 31-Parameter Flow Cytometry Panel for In-Depth Immunophenotyping of Human T-Cell Subsets Using Surface Markers.OMIP 071:一种用于使用表面标志物对人T细胞亚群进行深度免疫表型分析的31参数流式细胞术检测板。
Cytometry A. 2021 Mar;99(3):273-277. doi: 10.1002/cyto.a.24272. Epub 2020 Dec 10.
10
Association of serum 25-hydroxyvitamin D levels with severe necroinflammatory activity and inflammatory cytokine production in type I autoimmune hepatitis.血清 25-羟维生素 D 水平与 I 型自身免疫性肝炎严重坏死性炎症活动和炎症细胞因子产生的相关性。
PLoS One. 2020 Nov 5;15(11):e0239481. doi: 10.1371/journal.pone.0239481. eCollection 2020.